Citation Impact
Citing Papers
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
2000 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Conventional cancer therapy: promise broken or promise delayed?
1998
Effector Genes Altered in MCF-7 Human Breast Cancer Cells after Exposure to Fractionated Ionizing Radiation
2001
The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix
1997
Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma
1999 Standout
The RB and p53 pathways in cancer
2002 Standout
Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
2015
Increased Risk of Second Lung Cancer in Hodgkin’s Lymphoma Survivors: A Meta-analysis
2012
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
The biological basis of a comprehensive grading system for the adverse effects of cancer treatment
2003
Cell cycle checkpoint signaling through the ATM and ATR kinases
2001 Standout
Nodular Lymphocyte-Predominant Hodgkin Lymphoma
2007
Getting ready for the manned mission to Mars: the astronauts’ risk from space radiation
2007
Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers
2000
The complexity of p53 modulation: emerging patterns from divergent signals
1998
DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2
1997 Standout
A microRNA component of the p53 tumour suppressor network
2007 StandoutNature
Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer
1999 Standout
Analysis of Blood Lymphocyte Subsets in Children Living around Chernobyl Exposed Long-Term to Low Doses of Cesium-137 and Various Doses of Iodine-131
2000
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Effect of Solar Particle Event Radiation and Hindlimb Suspension on Gastrointestinal Tract Bacterial Translocation and Immune Activation
2012 StandoutNobel
Relative biological effectiveness (RBE) values for proton beam therapy
2002 Standout
A randomized double blind placebo controlled multicenter study of mesalazine for the prevention of acute radiation enteritis
1997
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Cardiac morbidity following modern treatment for Hodgkin lymphoma: Supra-additive cardiotoxicity of doxorubicin and radiation therapy
2008
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
2002 Standout
FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy
1999
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
Exploiting tumour hypoxia in cancer treatment
2004 Standout
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Comparison of three different mediastinal radiotherapy techniques in female patients: Impact on heart sparing and dose to the breasts
2006
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
HPV-associated head and neck cancer: a virus-related cancer epidemic
2010 Standout
Concomitant Irradiation and Dose-Escalating Carboplatin for Locally Advanced Carcinoma of the Uterine Cervix
1998
Postoperative Radiotherapy in Early Stage Carcinoma of the Uterine Cervix: Treatment Results and Prognostic Factors
1999
Graft-versus-host disease
2009 Standout
Mortality due to cancer treatment delay: systematic review and meta-analysis
2020 Standout
Acute Effects of Whole-Body Proton Irradiation on the Immune System of the Mouse
2000
Resveratrol Inhibits Cyclooxygenase-2 Transcription and Activity in Phorbol Ester-treated Human Mammary Epithelial Cells
1998 Standout
The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study
2002
Cancer treatment and survivorship statistics, 2012
2012 Standout
18F-FDG PET/CT bone/bone marrow findings in Hodgkin’s lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging
2010
Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002
2003
Genetic and epigenetic features in radiation sensitivity
2005
Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck
1996
The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy
1996
Relationship between DNA damage, rejoining and cell killing by radiation in mammalian cells
1996
Effects of Prolongation of Overall Treatment Time Due To Unplanned Interruptions During Radiotherapy of Different Tumor Sites and Practical Methods for Compensation
2007
Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of sulphasalazine in preventing acute gastrointestinal complications due to radiotherapy
2000
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Clinical Outcome and Tumour Microenvironmental Effects of Accelerated Radiotherapy with Carbogen and Nicotinamide
1999
Lymphedema beyond breast cancer
2010 Standout
Late Effects of Hodgkin’s Disease and Its Treatment
2009
The p53 pathway: positive and negative feedback loops
2005 Standout
Cervical cancer
2019 Standout
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Pediatric Hodgkin Lymphoma: Maximizing Efficacy and Minimizing Toxicity
2007
The Immunobiology of Low-Dose Total-Body Irradiation: More Questions than Answers
2000
Ionizing radiation activates IGF-1R triggering a cytoprotective signaling by interfering with Ku-DNA binding and by modulating Ku86 expression via a p38 kinase-dependent mechanism
2006
Total Body Irradiation and Acute Graft-Versus-Host Disease: The Role of Gastrointestinal Damage and Inflammatory Cytokines
1997
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
2000 StandoutNobel
Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression
2000 StandoutNobel
Requirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death Pathway
2000 StandoutScience
Revised Response Criteria for Malignant Lymphoma
2007 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors
2003
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction.
2002
Late cardiotoxicity after treatment for Hodgkin lymphoma
2006
Cancer treatment and survivorship statistics, 2016
2016 Standout
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
1999 Standout
Surfing the p53 network
2000 StandoutNature
The Danger Model: A Renewed Sense of Self
2002 StandoutScience
Cancer treatment and survivorship statistics, 2019
2019 Standout
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Cardiovascular Disease After Hodgkin Lymphoma Treatment
2015
Human prostate epithelium lacks Wee1A-mediated DNA damage-induced checkpoint enforcement
2007
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
DNA Double-Strand Breaks
2002 StandoutNobel
p53-dependent cell cycle arrests are preserved in DNA-activated protein kinase-deficient mouse fibroblasts.
1996
Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma
2015
GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease
2004 StandoutNobel
HIF-1 and human disease: one highly involved factor
2000 StandoutNobel
c-Abl Regulates p53 Levels under Normal and Stress Conditions by Preventing Its Nuclear Export and Ubiquitination
2001 StandoutNobel
hMutSα- and hMutLα-dependent phosphorylation of p53 in response to DNA methylator damage
1999 StandoutNobel
Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.
2006
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of T. Girinsky being referenced
Combined-Modality Therapy for Clinical Stage I or II Hodgkin's Lymphoma: Long-Term Results of the European Organisation for Research and Treatment of Cancer H7 Randomized Controlled Trials
2006
In vitro parameters and treatment outcome in head and neck cancers treated with surgery and/or radiation: Cell characterization and correlations with local control and overall survival
1994
A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment
2001
Les traitements par les radiations ionisantes dans les lymphomes. Indications actuelles et futures
2005
Involved-Node Radiotherapy and Modern Radiation Treatment Techniques in Patients With Hodgkin Lymphoma
2011
Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)
2013
Heart and coronary artery protection in patients with mediastinal Hodgkin lymphoma treated with intensity-modulated radiotherapy: Dose constraints to virtual volumes or to organs at risk?
2007
The conundrum of hodgkin lymphoma nodes: To be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines
2008
Thallium-201 scintigraphy is not predictive of late cardiac complications in patients with Hodgkin’s disease treated with mediastinal radiation
2000
Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: Preliminary correlations with local control and overall survival
1993
Dosimetric Benefits of Intensity-Modulated Radiotherapy Combined With the Deep-Inspiration Breath-Hold Technique in Patients With Mediastinal Hodgkin's Lymphoma
2011
Prospective Study of the Clinical Symptoms of Therapeutic Whole Body Irradiation
1993
Overall treatment time in advanced cervical carcinomas: A critical parameter in treatment outcome
1993
Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines
2006
Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin’s disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
2005
Les effets tardifs pulmonaires et cardiaques induits par les radiations ionisantes seules ou associées à la chimiothérapie
1997
Multicolor flow cytometry analysis of blood cell subsets in patients given total body irradiation before bone marrow transplantation
1995
Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents.
1995
Sensitivity to Radiation and Alkylating Agent of Peripheral Lymphocytes and Fibroblasts in a Hoyeraal-Hreidarsson Syndrome Patient
2003
Peripheral Blood Corticotropin-Releasing Factor, Adrenocorticotropic Hormone and Cytokine (Interleukin Beta, Interleukin 6, Tumor Necrosis Factor Alpha) Levels after High- and Low-Dose Total-Body Irradiation in Humans
1994
Is tumor cell radiation resistance correlated with metastatic ability?
1994